Antisense RNA Regulators for Plasmid DNA Yield
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing high copy plasmids are limited by the inability to increase yield without reengineering existing plasmids, leading to suboptimal productivity and purity in therapeutic applications, and existing high copy replicons often result in metabolic burden, instability, and toxicity to cells.
Innovation Solution
A method involving the use of anti-RNAI regulators, specifically antisense RNAs, is employed to induce plasmid production in E. coli cells, which improves plasmid yield by interfering with the copy number repressive function of RNAI and promoting primer formation, thereby enhancing plasmid replication without altering the target plasmid sequences.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If existing high copy replicons are used to increase plasmid yield, then plasmid production increases, but metabolic burden, instability, and toxicity to cells occur
Solution Approach 1:
The patent applies parameter changes by modifying the replication control mechanism through antisense RNA regulation. Instead of using high copy replicons that constitutively drive replication, the invention introduces a regulated system where plasmid copy number is controlled by the balance between RNAI (repressor) and antisense RNA (activator). This allows dynamic adjustment of replication parameters to achieve high yield while maintaining cell stability and avoiding toxicity.
2Productivity
If plasmid copy number is increased using conventional methods, then productivity improves, but reengineering of plasmid sequences is required
Solution Approach 1:
The patent uses an intermediary approach by introducing a separate regulatory RNA system (antisense RNA and RNAI) that acts as a mediator between the host cell and the plasmid replication machinery. This intermediary system allows control of plasmid copy number without directly modifying the plasmid's functional sequences, thereby avoiding the need to reengineer the plasmid itself while still achieving improved productivity.
3Productivity
If RNAI repressive function is not interfered with, then plasmid copy number remains controlled, but plasmid yield is limited
Solution Approach 1:
The patent applies preliminary anti-action by introducing antisense RNA that preemptively counteracts the RNAI repressive function before it can fully suppress plasmid replication. The antisense RNA binds to RNAI in advance, neutralizing its inhibitory effect and allowing primer formation and replication to proceed. This preliminary counter-action enables increased plasmid yield while maintaining some level of regulatory control through the balance between the two RNA molecules.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases plasmid DNA yield up to 5-fold for moderate copy plasmids and 3-fold for high copy plasmids, maintaining or improving plasmid integrity and reducing metabolic burden, thus enhancing productivity and purity.
Implementation Method 1
A method involving the use of anti-RNAI regulators, specifically antisense RNAs, is employed to induce plasmid production in E. coli cells, which improves plasmid yield by interfering with the copy number repressive function of RNAI and promoting primer formation
Data Source
AI summary
Improvements in plasmid DNA production technology are needed to insure the economic feasibility of future DNA vaccines and DNA therapeutics. General methods are described, by means of which it is possible to dramatically increase plasmid DNA productivity. These processes feature RNA based inducers of plasmid copy number.